What is the recommended perioperative intravenous amikacin dose for a 10‑kg child?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 14, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Perioperative Amikacin Dose in 10kg Child

For a 10 kg child requiring perioperative amikacin, administer 150 mg (15 mg/kg) as a single intravenous dose.

Dosing Rationale

The FDA-approved dosing for children with normal renal function is 15 mg/kg/day divided into 2-3 equal doses (7.5 mg/kg q12h or 5 mg/kg q8h), with a maximum daily dose not exceeding 15 mg/kg/day 1. For perioperative prophylaxis or single-dose therapy, the full daily dose of 15 mg/kg can be administered as a single dose.

Multiple guidelines consistently support the 15-30 mg/kg range for pediatric dosing 2, 3, 4, 3. The lower end of this range (15 mg/kg) is appropriate for:

  • Initial perioperative dosing
  • Children with normal renal function
  • Single-dose or short-term therapy

For a 10 kg child: 15 mg/kg × 10 kg = 150 mg

Administration Details

  • Route: Intravenous infusion over 30-60 minutes 1
  • Timing: Administer as a single perioperative dose
  • Preparation: Dilute in 50-100 mL of 0.9% sodium chloride or 5% dextrose

When to Consider Higher Dosing (20-30 mg/kg)

The upper dosing range may be warranted for:

  • Severe gram-negative infections requiring higher peak concentrations 5
  • Loading dose scenarios where rapid therapeutic levels are needed 6
  • Pseudomonas or resistant organisms with higher MICs 7

However, for routine perioperative use, 15 mg/kg is the standard and FDA-recommended dose.

Critical Safety Considerations

Renal Function Monitoring

  • Baseline: Obtain serum creatinine before administration 1
  • Contraindication: Do not use if significant renal impairment exists without dose adjustment
  • Post-operative: Monitor renal function if multiple doses are required

Ototoxicity Risk

  • Baseline audiometry is recommended for prolonged therapy (>7-10 days) but not necessary for single perioperative doses 3, 4
  • Risk increases with: concurrent diuretics, prolonged therapy, cumulative doses >100-120g 3
  • Amikacin causes primarily auditory toxicity (less vestibular dysfunction than streptomycin) 3

Therapeutic Drug Monitoring (TDM)

For single perioperative doses, TDM is not routinely necessary. However, if multiple doses are required:

  • Peak target: 30-40 mg/L (measured 30-90 minutes post-infusion) 1
  • Trough target: <5-10 mg/L (measured just before next dose) 2, 1
  • Peak concentrations >35 mcg/mL and trough >10 mcg/mL should be avoided 1

Common Pitfalls to Avoid

  1. Underdosing: Using 7.5 mg/kg as a single dose (this is the q12h divided dose, not the total daily dose)
  2. Overdosing: Exceeding 15 mg/kg/day total without clear indication for severe infection
  3. Rapid infusion: Administering as IV push rather than 30-60 minute infusion increases toxicity risk
  4. Ignoring renal function: Failing to assess baseline renal function before administration
  5. Concurrent nephrotoxins: Particular caution with vancomycin co-administration, which significantly increases nephrotoxicity risk 8

Duration Considerations

  • Single perioperative dose: No adjustment needed
  • If continued therapy required: Reassess at 7-10 days; limit duration when feasible 1
  • Beyond 10 days: Requires formal TDM and monitoring of renal, auditory, and vestibular function 1

References

Guideline

treatment of tuberculosis.

MMWR Recommendations and Reports, 2003

Research

Pharmacokinetics of once-daily amikacin in pediatric patients.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 1996

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.